Women in Science: How Medable’s Pamela Tenaerts is democratizing clinical trials
Pamela Tenaerts, chief scientific officer at Medable, is on a mission to democratize and diversify clinical trials.
Pamela Tenaerts, chief scientific officer at Medable, is on a mission to democratize and diversify clinical trials.
Patients with pulmonary arterial hypertension (PAH) may be able to take a single tablet instead of multiple types if a new drug is approved.
A small molecule drug candidate from Algiax Pharmaceuticals can reduce excitability of neurons in relation to chronic pain, dampening signal and reducing pain, a study shows.
Studies show a wearable monitor, described as a ‘game changer’ in the fight against Parkinson’s Disease (PD) has proven it is more than 95% accurate, PD Neurotechnology says.